You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Daniel Geiger Every time Daniel publishes a story, you’ll get an alert straight to your inbox!

Compass is a clinical-stage biotechnology company focused on developing psychedelics-based drugs for neuropsychiatric disorders. The analyst equates COMP360 to Spravato 2.0. Johnson & Johnson’s ...

The real-estate brokerage Compass announced on June 14 that it was laying off 10% of its employees. CEO Robert Reffkin addressed the layoffs in an emailed memo to staff viewed by Insider. He said the ...

Compass Inc. (NYSE:COMP) shares fell more than 12% while Anywhere Real Estate Inc. (NYSE:HOUS) jumped over 52% on Monday after the companies announced a $10 billion all-stock merger, including debt.

Compass cements its dominance in U.S. real estate brokerage with an all-stock acquisition of Anywhere Real Estate. The Anywhere deal more than doubles Compass' adjusted EBITDA and revenue base, ...